Home
About
News & Events

News & Events

Latest events October 1, 2026

UEG Week 2026

Nordic Bioscience will be attending UEG Week 2026 in Barcelona, Spain. The 4-day congress will take place from October 17-20 and unites experts on digestive health from all over the world. Our team will present various presentations about how our biomarkers can be applied in gastrointestinal diseases. We invite you to take a look at […]

Read article

Latest events September 28, 2026

EASD 2026

Nordic Bioscience will attend this year’s EASD, taking place from 28 September – 02 October in Milan, Italy. Organized by the European Association for the Study of Diabetes, this conference focuses on diabetes, which is why we will present how our biomarkers can be applied in this field. Our team will present three short oral […]

Read article

Latest events September 28, 2026

EADV Congress 2026

Nordic Bioscience’s team will be attending this year’s EADV Congress, taking place from 30 September – 03 October in Vienna, Austria. Organized by the European Academy of Dermatology and Venereology, this is Europe’s leading congress on skin and sexual health. Our dermatology team will be presenting two posters that cover hidradenitis suppurativa and atopic dermatitis: […]

Read article

Latest events September 13, 2026

From Sample to Insight: The Clinical Laboratory Chain of Responsibility | Webinar

Safeguarding Samples, Data, and Decisions Across the Clinical Biomarker Journey Overview A clinical laboratory does far more than process samples and report results. Every patient-derived sample passes through a chain of interconnected processes before it becomes interpretable biomarker data. Sample collection and handling, traceability, laboratory operations, analytical performance, data interpretation, and final delivery can all […]

Read article

PRESS RELEASE: KKR to sell minority stake in Nordic Bioscience to Founder Claus Christiansen

Copenhagen, 3 September 2026 – Nordic Bioscience, a global leader in biomarkerdevelopment, and KKR, a leading global investment firm, today announced that KKR hasentered into an agreement to sell its 10% minority stake in Nordic Bioscience to the company’sfounder and majority shareholder, Claus Christiansen. KKR invested in Nordic Bioscience in 2021 through its Health Care […]

Read article

Latest events August 26, 2026

Fibroblast Activity and Tissue Destruction in Autoimmune Diseases | Webinar

Fibroblast Activity and Tissue Destruction in Autoimmune Diseases: Understanding Tissue Activity and Its Implications for Drug Development The body continuously regenerates, which inherently means that tissue is constantly being broken down and formed. In rheumatic diseases we usually focus on inflammation and immune activity, but inflammation is what starts the process, not what causes the […]

Read article

News

Hot and Cold Fibrosis: The Role of Serum Biomarkers to Assess the Immune Mechanisms and ECM-Cell Interactions in Human Fibrosis

March 13, 2025

Read article

Best of 2024 Publications Digest

January 27, 2025

Read article

PRESS RELEASE: KeyBioscience, a Fully Owned Subsidiary and Affiliate of Nordic Bioscience, Announces Extension of Strategic Collaboration with Lilly

October 10, 2024

Read article

1 2 3 4 5 … 8

Upcoming events

From Sample to Insight: The Clinical Laboratory Chain of Responsibility | Webinar

October 28, 2026

View event

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Cardiovascular diseases

Dermatology

Gastrointestinal diseases

Hepatic diseases

Kidney diseases

Neuroscience

Obesity

Oncology

Respiratory diseases

Rheumatic diseases

What we offer

Biomarker portfolio

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Our services

Lab solutions

Biomarker Solutions

Biomarker Portfolio

Why Biomarkers?

Kit in a Box

Measure specific protein fragments

Our technology

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

About Nordic Bioscience

Who we are

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Cardiovascular diseases

Dermatology

Gastrointestinal diseases

Hepatic diseases

Kidney diseases

Neuroscience

Obesity

Oncology

Respiratory diseases

Rheumatic diseases

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Biomarker Solutions

Biomarker Portfolio

Why Biomarkers?

Kit in a Box

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

News & Events

UEG Week 2026

EASD 2026

EADV Congress 2026

From Sample to Insight: The Clinical Laboratory Chain of Responsibility | Webinar

PRESS RELEASE: KKR to sell minority stake in Nordic Bioscience to Founder Claus Christiansen

Fibroblast Activity and Tissue Destruction in Autoimmune Diseases | Webinar

News

Hot and Cold Fibrosis: The Role of Serum Biomarkers to Assess the Immune Mechanisms and ECM-Cell Interactions in Human Fibrosis

Best of 2024 Publications Digest

PRESS RELEASE: KeyBioscience, a Fully Owned Subsidiary and Affiliate of Nordic Bioscience, Announces Extension of Strategic Collaboration with Lilly

Nordic Bioscience Receives Letter of Support from the FDA for the CPa9-HNE Biomarker in IBD

Nordic Bioscience Secures Continuous CAP Accreditation For Another Two Years

Nordic Bioscience Introduces the FIB-NIT™ Biomarker Panel for Fibrotic Diseases

Upcoming events

From Sample to Insight: The Clinical Laboratory Chain of Responsibility | Webinar